165 related articles for article (PubMed ID: 21371516)
1. Reciprocal signalling between NR2 subunits of the NMDA receptor and neuregulin1 and their role in schizophrenia.
Geddes AE; Huang XF; Newell KA
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):896-904. PubMed ID: 21371516
[TBL] [Abstract][Full Text] [Related]
2. Perinatal phencyclidine treatment alters neuregulin 1/erbB4 expression and activation in later life.
du Bois TM; Newell KA; Huang XF
Eur Neuropsychopharmacol; 2012 May; 22(5):356-63. PubMed ID: 21962913
[TBL] [Abstract][Full Text] [Related]
3. Antipsychotic treatment and neuregulin 1-ErbB4 signalling in schizophrenia.
Pan B; Huang XF; Deng C
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):924-30. PubMed ID: 21513767
[TBL] [Abstract][Full Text] [Related]
4. A neuregulin 1 transmembrane domain mutation causes imbalanced glutamatergic and dopaminergic receptor expression in mice.
Newell KA; Karl T; Huang XF
Neuroscience; 2013 Sep; 248():670-80. PubMed ID: 23811072
[TBL] [Abstract][Full Text] [Related]
5. Schizophrenia: more evidence for less glutamate.
Morrison PD; Pilowsky LS
Expert Rev Neurother; 2007 Jan; 7(1):29-31. PubMed ID: 17187494
[TBL] [Abstract][Full Text] [Related]
6. The ERBB4 intracellular domain (4ICD) regulates NRG1-induced gene expression in hippocampal neurons.
Allison JG; Das PM; Ma J; Inglis FM; Jones FE
Neurosci Res; 2011 Jun; 70(2):155-63. PubMed ID: 21352860
[TBL] [Abstract][Full Text] [Related]
7. Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology.
Harrison PJ; Law AJ
Biol Psychiatry; 2006 Jul; 60(2):132-40. PubMed ID: 16442083
[TBL] [Abstract][Full Text] [Related]
8. Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia.
Corfas G; Roy K; Buxbaum JD
Nat Neurosci; 2004 Jun; 7(6):575-80. PubMed ID: 15162166
[TBL] [Abstract][Full Text] [Related]
9. Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia.
Hahn CG; Wang HY; Cho DS; Talbot K; Gur RE; Berrettini WH; Bakshi K; Kamins J; Borgmann-Winter KE; Siegel SJ; Gallop RJ; Arnold SE
Nat Med; 2006 Jul; 12(7):824-8. PubMed ID: 16767099
[TBL] [Abstract][Full Text] [Related]
10. Positive and negative symptoms in schizophrenia: the NMDA receptor hypofunction hypothesis, neuregulin/ErbB4 and synapse regression.
Bennett M
Aust N Z J Psychiatry; 2009 Aug; 43(8):711-21. PubMed ID: 19629792
[TBL] [Abstract][Full Text] [Related]
11. Neuregulin1 (NRG1) signaling through Fyn modulates NMDA receptor phosphorylation: differential synaptic function in NRG1+/- knock-outs compared with wild-type mice.
Bjarnadottir M; Misner DL; Haverfield-Gross S; Bruun S; Helgason VG; Stefansson H; Sigmundsson A; Firth DR; Nielsen B; Stefansdottir R; Novak TJ; Stefansson K; Gurney ME; Andresson T
J Neurosci; 2007 Apr; 27(17):4519-29. PubMed ID: 17460065
[TBL] [Abstract][Full Text] [Related]
12. Neuregulin1 downregulates postsynaptic GABAA receptors at the hippocampal inhibitory synapse.
Okada M; Corfas G
Hippocampus; 2004; 14(3):337-44. PubMed ID: 15132433
[TBL] [Abstract][Full Text] [Related]
13. Disrupted-in-schizophrenia 1 and neuregulin 1 are required for the specification of oligodendrocytes and neurones in the zebrafish brain.
Wood JD; Bonath F; Kumar S; Ross CA; Cunliffe VT
Hum Mol Genet; 2009 Feb; 18(3):391-404. PubMed ID: 18996920
[TBL] [Abstract][Full Text] [Related]
14. Behavioral, Neurophysiological, and Synaptic Impairment in a Transgenic Neuregulin1 (NRG1-IV) Murine Schizophrenia Model.
Papaleo F; Yang F; Paterson C; Palumbo S; Carr GV; Wang Y; Floyd K; Huang W; Thomas CJ; Chen J; Weinberger DR; Law AJ
J Neurosci; 2016 Apr; 36(17):4859-75. PubMed ID: 27122041
[TBL] [Abstract][Full Text] [Related]
15. Neuregulin1/ErbB4-induced migration in ST14A striatal progenitors: calcium-dependent mechanisms and modulation by NMDA receptor activation.
Pregno G; Zamburlin P; Gambarotta G; Farcito S; Licheri V; Fregnan F; Perroteau I; Lovisolo D; Bovolin P
BMC Neurosci; 2011 Oct; 12():103. PubMed ID: 21991932
[TBL] [Abstract][Full Text] [Related]
16. Disruption to social dyadic interactions but not emotional/anxiety-related behaviour in mice with heterozygous 'knockout' of the schizophrenia risk gene neuregulin-1.
O'Tuathaigh CM; O'Connor AM; O'Sullivan GJ; Lai D; Harvey R; Croke DT; Waddington JL
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):462-6. PubMed ID: 17980471
[TBL] [Abstract][Full Text] [Related]
17. The neuregulin-I/ErbB signaling system in development and disease.
Britsch S
Adv Anat Embryol Cell Biol; 2007; 190():1-65. PubMed ID: 17432114
[TBL] [Abstract][Full Text] [Related]
18. Neuregulin 1-erbB4 pathway in schizophrenia: From genes to an interactome.
Banerjee A; Macdonald ML; Borgmann-Winter KE; Hahn CG
Brain Res Bull; 2010 Sep; 83(3-4):132-9. PubMed ID: 20433909
[TBL] [Abstract][Full Text] [Related]
19. Endoplasmic reticulum-associated degradation of the NR1 but not the NR2 subunits of the N-methyl-D-aspartate receptor induced by inhibition of the N-glycosylation in cortical neurons.
Gascón S; García-Gallo M; Renart J; Díaz-Guerra M
J Neurosci Res; 2007 Jun; 85(8):1713-23. PubMed ID: 17455306
[TBL] [Abstract][Full Text] [Related]
20. Neuregulin 1 and schizophrenia.
Stefansson H; Steinthorsdottir V; Thorgeirsson TE; Gulcher JR; Stefansson K
Ann Med; 2004; 36(1):62-71. PubMed ID: 15000348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
